Lanjuan Li
-
- Monoclonal and Polyclonal Antibodies Research 3
- Immunology top 10%
- interferon and immune responses 2
- Immunotherapy and Immune Responses 2
- Immunology and Allergy top 10%
-
- Glycosylation and Glycoproteins Research 2
-
- Liver physiology and pathology 3
-
- Liver Disease Diagnosis and Treatment 2
-
- Pancreatic and Hepatic Oncology Research 1
-
- SARS-CoV-2 and COVID-19 Research 1
Lanjuan Li
8 papers receiving 707 citations
Peers
Comparison fields: 5 of 65
- Radiology, Nuclear Medicine and Imaging 412
- Immunology 356
- Immunology and Allergy 70
- Molecular Biology 523
- Hepatology 48
Countries citing papers authored by Lanjuan Li
This map shows the geographic impact of Lanjuan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanjuan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanjuan Li more than expected).
Fields of papers citing papers by Lanjuan Li
This network shows the impact of papers produced by Lanjuan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanjuan Li. The network helps show where Lanjuan Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lanjuan Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 11 | |
| 5 | 2020 | 107 | |
| 6 | 2018 | 4 | |
| 7 | Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-gamma/adriamycin-induced apoptosis of Hep G2 hepatoma cells. | 2007 | 15 |
| 8 | 1982 | 115 | |
| 9 | 1980 | 419 | |
| 10 | 1979 | 127 |
About Lanjuan Li
Lanjuan Li is a scholar working on Hepatology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 10 papers that have together received 803 indexed citations. Recurring topics across this work include Liver physiology and pathology (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), interferon and immune responses (2 papers), Glycosylation and Glycoproteins Research (2 papers), Immunotherapy and Immune Responses (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (412 citations), Immunology (356 citations) and Immunology and Allergy (70 citations). Lanjuan Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Herbert F. Oettgen, Lloyd J. Old, Kenneth O. Lloyd, Hisami Ikeda, Wolfgang Dippold, Hiroshi Shiku, Qiongling Bao, Chenxia Hu, Lingfei Zhao and Lingjian Zhang. Their work appears in journals such as The Journal of Experimental Medicine, Biomaterials, Biomedicine & Pharmacotherapy, BMC Infectious Diseases and International Journal of Biological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.